{"id":109751,"date":"2026-01-08T15:30:11","date_gmt":"2026-01-08T13:30:11","guid":{"rendered":"https:\/\/digitrendz.blog\/?p=109751"},"modified":"2026-01-08T15:30:11","modified_gmt":"2026-01-08T13:30:11","slug":"ai-now-writing-prescription-refills-in-utah","status":"publish","type":"post","link":"https:\/\/digitrendz.blog\/z\/newswire\/artificial-intelligence\/109751\/ai-now-writing-prescription-refills-in-utah\/","title":{"rendered":"AI Now Writing Prescription Refills in Utah"},"content":{"rendered":"
\u25bc Summary<\/summary>\n

– Utah is piloting a program allowing an AI to prescribe medication refills without direct human oversight, which public advocates have labeled as dangerous.
– The program operates under Utah’s “regulatory sandbox,” which temporarily waives state regulations to let businesses test innovative services like this telehealth AI.
– The service is provided by Doctronic, a startup whose AI chatbot must be consulted first by patients before they can book a $39 appointment with a real, licensed doctor.
– According to the company’s own non-peer-reviewed study, its AI’s diagnosis matched a clinician’s in 81% of cases, and its treatment plan was consistent in 99% of cases.
– In Utah, the AI can now refill prescriptions for a $4 fee, accessing patient history to renew only 190 common chronic condition medications, excluding pain, ADHD, and injected drugs.
<\/p>\n<\/details>\n\n

<\/p>\n\n

A<\/mark> new pilot program in Utah<\/a> is authorizing artificial intelligence<\/a> to manage prescription refills for patients, operating without the immediate oversight of a human physician. This initiative, which some public advocates have labeled as potentially risky, functions under the state’s “regulatory sandbox<\/a>.” This framework permits businesses to test novel products or services while certain standard regulations are temporarily suspended. The Utah Department of Commerce<\/a> has collaborated with a telehealth startup named Doctronic<\/a>, which provides an AI chatbot service.<\/p>\n\n

Doctronic offers a free national service where patients initially interact with its “AI doctor” chatbot<\/strong>. Following this automated consultation, patients can pay $39 to schedule a virtual appointment<\/a> with a licensed physician in their state. Crucially, the AI chatbot<\/a> serves as the mandatory first point of contact<\/strong> for anyone seeking an appointment through the platform.<\/p>\n\n

The company has published a non-peer-reviewed preprint article analyzing 500 of its telehealth cases. In this report, Doctronic asserts that its AI’s diagnosis aligned with a human clinician’s assessment 81 percent of the time<\/strong>. Furthermore, the AI’s proposed treatment plan was reportedly consistent with a doctor’s plan in 99 percent of the reviewed cases.<\/p>\n\n

For Utah residents specifically, the Doctronic chatbot now possesses an expanded capability: it can directly refill certain prescriptions without involving a doctor, charging a service fee<\/a> of $4. After a patient logs in and confirms their state residency, the AI can access the individual’s prescription history<\/a> and present a list of medications eligible for renewal. According to reports, the chatbot is restricted to renewing prescriptions for 190 common medications<\/strong> used to manage chronic conditions<\/a>. Significant exclusions apply, barring the AI from refilling medications for pain, ADHD, and any drugs that are administered via injection.<\/p>\n\n

(Source: Ars Technica<\/a>)<\/em><\/p>","protected":false},"excerpt":{"rendered":"

Utah is piloting a program allowing an AI chatbot to manage prescription refills without direct, immediate physician oversight, operating under a temporary regulatory suspension framework. The AI chatbot from Doctronic serves as the mandatory first contact for patients and, in a company analysis,…<\/p>\n","protected":false},"author":1,"featured_media":109750,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_themeisle_gutenberg_block_has_review":false,"cybocfi_hide_featured_image":"","footnotes":""},"categories":[57,3247,20157,3327,3254],"tags":[37042,148149,148150,148151,148148],"entities":[148152,64803,7359,148153],"class_list":["post-109751","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tech-news","category-artificial-intelligence","category-health","category-newswire","category-technology","tag-ai-healthcare","tag-chatbot-diagnostics","tag-prescription-refills","tag-telemedicine-regulation","tag-utah-pilot-program","entity-doctronic","entity-politico-2","entity-utah","entity-utah-department-of-commerce"],"_links":{"self":[{"href":"https:\/\/digitrendz.blog\/z\/wp-json\/wp\/v2\/posts\/109751","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/digitrendz.blog\/z\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/digitrendz.blog\/z\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/digitrendz.blog\/z\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/digitrendz.blog\/z\/wp-json\/wp\/v2\/comments?post=109751"}],"version-history":[{"count":0,"href":"https:\/\/digitrendz.blog\/z\/wp-json\/wp\/v2\/posts\/109751\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/digitrendz.blog\/z\/wp-json\/wp\/v2\/media\/109750"}],"wp:attachment":[{"href":"https:\/\/digitrendz.blog\/z\/wp-json\/wp\/v2\/media?parent=109751"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/digitrendz.blog\/z\/wp-json\/wp\/v2\/categories?post=109751"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/digitrendz.blog\/z\/wp-json\/wp\/v2\/tags?post=109751"},{"taxonomy":"entity","embeddable":true,"href":"https:\/\/digitrendz.blog\/z\/wp-json\/wp\/v2\/entities?post=109751"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}